Newsroom

Filtrer par

How TRB is proactively addressing the new European Medical Devices Regulation (MDR)

Learn More
TRB Chemedica International S.A. and InnoMedica Holding AG enter in a long-term relationship regarding the production of GM1 (monosialotetrahexosylganglioside) and its development as a liposomal formulation under the trade name Talineuren®

TRB Chemedica announces a collaboration with InnoMedica to develop liposomal GM1

Learn More
Hyaluronic Acid injection and cost TRB Chemedica

Are more expensive products any more clinically effective?


Learn More
european-business-trb-chemedica-interview

Read the European Business magazine interviews of Alessandro di Napoli

Learn More

Presentation of DISSCO results at the WCO-IOF-ESCEO congress in Paris (past event)

Learn More